Analysts’ Updated EPS Estimates for March 24th (AG, BP, CNTX, EQNR, EVTL, FOM, GEMI, GLPEY, LAR, LFCR)

Analysts’ updated eps estimates for Tuesday, March 24th:

First Majestic Silver (TSE:AG) was upgraded by analysts at BMO Capital Markets from a market perform rating to an outperform rating. BMO Capital Markets currently has C$35.00 target price on the stock.

BP (NYSE:BP) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. The firm currently has $49.40 target price on the stock.

Context Therapeutics (NASDAQ:CNTX) had its buy rating reissued by analysts at D. Boral Capital. The firm currently has a $9.00 target price on the stock.

Equinor ASA (NYSE:EQNR) was upgraded by analysts at Morgan Stanley from an underweight rating to an equal weight rating. They currently have $40.40 target price on the stock.

Vertical Aerospace (NYSE:EVTL) had its buy rating reiterated by analysts at D. Boral Capital. The firm currently has a $12.00 target price on the stock.

Foran Mining (CVE:FOM) was downgraded by analysts at Scotiabank from an outperform rating to a sector perform rating. They currently have C$6.60 price target on the stock, up from their previous price target of C$6.00.

Gemini Space Station (NASDAQ:GEMI) had its price target trimmed by Rosenblatt Securities from $11.50 to $9.00. Rosenblatt Securities currently has a buy rating on the stock.

Galp Energia SGPS (OTCMKTS:GLPEY) was downgraded by analysts at Morgan Stanley from an overweight rating to an equal weight rating.

Lithium Americas (Argentina) (NYSE:LAR) had its price target boosted by TD Securities from $7.00 to $9.00. They currently have a buy rating on the stock.

Lifecore Biomedical (NASDAQ:LFCR) had its outperform rating reaffirmed by analysts at Barrington Research. Barrington Research currently has a $5.50 price target on the stock.

NRx Pharmaceuticals (NASDAQ:NRXP) had its buy rating reiterated by analysts at D. Boral Capital. They currently have a $34.00 price target on the stock.

Repsol (OTCMKTS:REPYY) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating.

Shell (NYSE:SHEL) was downgraded by analysts at Morgan Stanley from an overweight rating to an equal weight rating.

TransAlta (TSE:TA) (NYSE:TAC) was upgraded by analysts at National Bank Financial from a sector perform rating to an outperform rating. The firm currently has C$22.00 target price on the stock.

Turn Therapeutics (NASDAQ:TTRX) had its buy rating reiterated by analysts at D. Boral Capital. D. Boral Capital currently has a $8.00 price target on the stock.